Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
- Mirjam Crul*
- , Nadja E. Schoemaker
- , Dick Pluim
- , Marc Maliepaard
- , René W.M. Underberg
- , Margaret Schot
- , Rolf W. Sparidans
- , Paul Baas
- , Jos H. Beijnen
- , Nico Van Zandwijk
- , Jan H.M. Schellens
*Corresponding author for this work
- Netherlands Cancer Institute
- Slotervaart Hospital
- Utrecht University
- Department of Thoracic Oncology
Research output: Contribution to journal › Article › Academic › peer-review